home / stock / imund / imund short
Short Information | Immune Therapeutics (OTCMKTS:IMUND)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 11,385 |
Total Actual Volume | 32,468 |
Short Trends | |
---|---|
Cover Days | 7 |
Short Days | 4 |
No Change Days | 5 |
Averages | |
---|---|
Average Short Volume | 569 |
Average Short Percentage | 28.24% |
Is there a IMUND Short Squeeze or Breakout about to happen?
See the IMUND Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
06-03-2021 | $5.75 | $5.25 | $5.75 | $5.25 | 573 | 261 | 45.55% |
06-02-2021 | $5.74 | $5.74 | $5.74 | $5.74 | 566 | 340 | 60.07% |
06-01-2021 | $5.5 | $5.5 | $5.5 | $5.25 | 1,336 | 571 | 42.74% |
05-28-2021 | $6 | $5.83 | $6 | $5.83 | 300 | 133 | 44.33% |
05-26-2021 | $6.01 | $6.5 | $6.5 | $6 | 913 | 24 | 2.63% |
05-25-2021 | $8.05 | $6 | $9.648 | $5.905 | 10,203 | 2,538 | 24.88% |
05-24-2021 | $7.5 | $7.5 | $7.5 | $7.5 | 2,004 | 35 | 1.75% |
05-21-2021 | $7.19 | $8.5 | $10 | $7.19 | 1,374 | 806 | 58.66% |
05-20-2021 | $6.16 | $5.2 | $6.16 | $5 | 3,150 | 1,955 | 62.06% |
05-19-2021 | $7.2 | $7 | $7.5 | $6.5 | 2,438 | 1,893 | 77.65% |
05-18-2021 | $7.25 | $7 | $7.25 | $7 | 692 | 3 | 0.43% |
05-17-2021 | $7.01 | $7.25 | $7.25 | $7.01 | 1,818 | 756 | 41.58% |
05-14-2021 | $8 | $8 | $8 | $2.55 | 4,854 | 1,496 | 30.82% |
05-13-2021 | $13.15 | $13.15 | $13.15 | $13.15 | 457 | 100 | 21.88% |
05-11-2021 | $19.95 | $13.5 | $19.95 | $13.5 | 1,013 | 374 | 36.92% |
05-10-2021 | $19.81 | $12.9 | $19.81 | $12 | 777 | 100 | 12.87% |
News, Short Squeeze, Breakout and More Instantly...
Immune Therapeutics Company Name:
IMUND Stock Symbol:
OTCMKTS Market:
Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC Pink: IMUN) (“Biostax”), a hub and spoke biotech development engine, sadly announces the passing of H. Louis Salomonksy, a dedicated member of its Board of Directors. Mr. Salomonksy pas...
Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp . (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine, announces the signing of a research collaboration agreement with Immgenuity, Inc . The joint resear...
Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) ("Biostax"), a hub-and-spoke biotech development engine, announces that they have accepted the transfer of three Investigational New Drug Applications (IND) for the drug candidate, JKB-12...